Gaso-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, designed to manage gastrointestinal disorders involving acid-related symptoms and motility disturbances. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric emptying and alleviates symptoms such as nausea, vomiting, and bloating by enhancing gastrointestinal motility without crossing the blood-brain barrier significantly, thus minimizing central nervous system side effects. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of Domperidone and Pantoprazole in Gaso-DSR Capsule offers comprehensive management of upper gastrointestinal symptoms by addressing both delayed gastric emptying and excessive acid secretion. This combination is particularly beneficial in patients presenting with dyspepsia, GERD with motility issues, and other functional gastrointestinal disorders. Gaso-DSR Capsule should be used under medical supervision, considering contraindications such as hypersensitivity to components, underlying cardiac conditions, and concurrent medications that may interact adversely. Patient adherence to prescribed dosage and monitoring for potential side effects are essential for optimal therapeutic outcomes.